TAKEDA PHARMACEUTICAL CO LTD
TAK
52 insider filings · Latest: Sep 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Sep 16 1:12 AM | Lauren Rusckowski DupreyChief Transformation Officer | Sale | 34,535 | $18.54 | $640.3K | 191,522(D) | View → |
| Sep 10, 2026 | Sep 10 12:00 PM | Lauren Rusckowski Duprey | Proposed Sale | 34,535 | $18.37 | $634.4K | — | View → |
| Sep 2, 2026 | Sep 4 1:49 AM | Andrew Stewart PlumpDirector, President, R&D | Sale | 116,191 | $18.49 | $2.1M | 145,465(I) | View → |
| Sep 2, 2026 | Sep 2 8:14 PM | Plump Andrew Stewart | Proposed Sale | 116,191 | $18.49 | $2.1M | — | View → |
| Aug 19, 2026 | Aug 21 8:30 PM | Andrew Stewart PlumpDirector, President, R&D | Sale | 19,651 | $18.49 | $363.3K | 261,656(I) | View → |
| Aug 18, 2026 | Aug 19 8:15 PM | Nicola Deidre Petal GreenwayChief Human Resources Officer | Sale | 12,980 | $18.11 | $235.1K | 40,049(D) | View → |
| Aug 19, 2026 | Aug 19 7:58 PM | Plump Andrew Stewart | Proposed Sale | 19,651 | $18.49 | $363.3K | — | View → |
| Aug 14, 2026 | Aug 14 8:10 PM | Nicola Greenway | Proposed Sale | 12,980 | $17.39 | $225.7K | — | View → |
| Aug 10, 2026 | Aug 13 1:54 AM | Awny Samaan Botros FarajallahChief Medical Officer | Sale | 14,006 | $17.10 | $239.5K | 116,177(D) | View → |
| Aug 10, 2026 | Aug 13 1:53 AM | Ramy Riad Ahmed IbrahimPresident, PDT BU | Sale | 7,277 | $17.10 | $124.4K | 102,588(D) | View → |
| Aug 10, 2026 | Aug 13 1:53 AM | Rhonda Janice PachecoPresident, U.S. Business Unit | Sale | 16,901 | $17.10 | $289.0K | 182,507(D) | View → |
| Aug 10, 2026 | Aug 13 1:51 AM | Lauren Rusckowski DupreyChief Transformation Officer | Sale | 47,586 | $17.10 | $813.7K | 226,057(D) | View → |
| Aug 10, 2026 | Aug 13 1:50 AM | Andrew Stewart PlumpDirector, President, R&D | Sale | 165,393 | $17.10 | $2.8M | 766,569(D) | View → |
| Aug 10, 2026 | Aug 13 1:46 AM | Agosti Marcello PignagnoliHead, Strat. & Port. Dev | Sale | 22,957 | $17.10 | $392.6K | 176,977(D) | View → |
| Aug 10, 2026 | Aug 13 1:45 AM | Teresa Marie BitettiPresident, OBU | Sale | 50,012 | $17.10 | $855.2K | 252,010(D) | View → |
| Aug 10, 2026 | Aug 13 1:42 AM | Elaine Mary ShannonPres., Global Supply & Quality | Sale | 3,978 | $17.10 | $68.0K | 63,333(D) | View → |
| Aug 10, 2026 | Aug 13 1:39 AM | Gabriele RicciChief Data & Tech. Officer | Sale | 25,088 | $17.10 | $429.0K | 171,654(D) | View → |
| Aug 10, 2026 | Aug 13 1:28 AM | Nicola Deidre Petal GreenwayChief Human Resources Officer | Sale | 6,774 | $17.10 | $115.8K | 53,029(D) | View → |
| Aug 10, 2026 | Aug 13 1:27 AM | Julie So-Young KimDirector, President and CEO | Sale | 89,090 | $17.10 | $1.5M | 391,489(D) | View → |
| Aug 10, 2026 | Aug 13 1:25 AM | Giles Richard PlatfordPresident, IBU | Sale | 31,083 | $17.10 | $531.5K | 315,838(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 6 10:29 PM | Steven GillisDirector | Disposition | 1,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:29 PM | Steven GillisDirector | Grant/Award | 1,319 | — | 1,319(D) | View → |
| Jul 10, 2026 | Jul 6 10:28 PM | John MaraganoreDirector | Disposition | 1,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:28 PM | John MaraganoreDirector | Grant/Award | 1,319 | — | 1,319(D) | View → |
| Jul 10, 2026 | Jul 6 10:28 PM | Kimberly A. ReedDirector | Disposition | 1,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:28 PM | Kimberly A. ReedDirector | Grant/Award | 1,319 | — | 1,319(D) | View → |
| Jul 10, 2026 | Jul 6 10:14 PM | Masami IijimaDirector | Disposition | 2,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:14 PM | Masami IijimaDirector | Grant/Award | 1,937 | — | 1,937(D) | View → |
| Jul 1, 2026 | Jul 6 10:12 PM | Bruce D BroussardDirector | Grant/Award | 1,319 | — | 1,319(D) | View → |
| Jul 1, 2026 | Jul 6 10:11 PM | Paulus StoffelsDirector | Grant/Award | 1,307 | — | 1,307(D) | View → |
| Jul 1, 2026 | Jul 6 10:10 PM | Koichiro KimuraDirector | Grant/Award | 1,937 | — | 1,937(D) | View → |
| Jul 10, 2026 | Jul 6 10:10 PM | Miki TsusakaDirector | Disposition | 2,152 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:10 PM | Miki TsusakaDirector | Grant/Award | 1,937 | — | 1,937(D) | View → |
| Jul 10, 2026 | Jul 6 10:09 PM | Asuka MiyabashiraPresident, Japan Pharma B.U. | Disposition | 1,022 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:09 PM | Asuka MiyabashiraPresident, Japan Pharma B.U. | Grant/Award | 1,994 | — | 666(D) | View → |
| Jul 10, 2026 | Jul 6 10:09 PM | Milano FurutaDirector, Chief Financial Officer | Disposition | 16,619 | — | 0(D) | View → |
| Jul 1, 2026 | Jul 6 10:09 PM | Milano FurutaDirector, Chief Financial Officer | Grant/Award | 12,864 | — | 4,288(D) | View → |
| Jul 1, 2026 | Jul 6 10:02 PM | Julie So-Young KimDirector, President and CEO | Grant/Award | 23,225 | — | 7,743(D) | View → |
| Apr 27, 2026 | Apr 28 10:08 AM | Christophe Pierre WeberDirector, President and CEO | Grant/Award | 78,978 | — | 125,345(D) | View → |
| Apr 27, 2026 | Apr 28 10:08 AM | Milano FurutaDirector, Chief Financial Officer | Grant/Award | 7,814 | — | 16,619(D) | View → |